Animal health and veterinary products demand precise safety, efficacy, and residue data for global markets - but outsourcing risks inconsistent GLP studies, target animal variability, and regulatory delays under FDA CVM and EMA CVMP. Aventiq Bio acts as your independent technical steward in India's capable ecosystem, ensuring VICH/GLP compliance, robust TAS and residue studies, and export-ready manufacturing - reducing time-to-market and protecting your portfolio with 40–60% cost advantages.
India is rapidly becoming a key player in veterinary biologicals, drug products, and feed additives, with facilities offering GLP-compliant labs, large-scale livestock trials, and growing expertise in companion animal health. Strengths include cost efficiency, diverse animal models, and increasing alignment with FDA CVM, EMA CVMP, and VICH standards - ideal for "China+1" diversification.
Aventiq Bio vets partners for technical maturity and regulatory readiness, enabling faster global market access.
We deliver independent technical stewardship to ensure your animal health products meet global safety, efficacy, and regulatory standards with speed and certainty.
Press Enter to search